Purchase Order 75N91018P00618

This is a $114,966.00 firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Gene Square Bio-Technology LTD, a for-profit limited liability company based in China. The contract is for genetic studies of myeloid and lymphoid malignancy in China in support of NCI's Division of Cancer Epidemiology and Genetics. The work will involve scanning 2,129 DNA samples from the NCI's AsiaLymph study...

This federal contract was awarded by a U.S. government agency to Reprocell U.S.A., Inc., a for-profit organization that specializes in providing biological materials and related services to support biomedical research. The contract is for DNA sample analysis, with a firm fixed price of $73,647.00 and a completion date of April 30, 2008. The work is being performed in Laurel, Maryland and was awarded on May 1, 2007 without any set-aside designation. Reprocell U.S.A., Inc. has primarily worked...

This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Labcorp Early Development Laboratories Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The contract, valued at $113,830.32, is for the company to perform whole genome DNA methylation profiling and genotyping on 580 DNA samples. The work is to be conducted at the contractor's facility in...

The NIH Clinical Center awarded a $12,000 firm fixed-price purchase order to Laboratory Corporation of America (LabCorp) on February 13, 2025, for laboratory testing and genotyping services related to congenital adrenal hyperplasia (CAH) research. The contract encompasses genetic analysis and measurement of multiple CAH-specific hormones, including 11-oxo-androgens, with services to be performed at LabCorp's Greenwood Village, Colorado facility. No set-aside designation was applied to this...

Quest Diagnostics Incorporated will provide laboratory testing and analysis services to the National Cancer Institute (NCI), an institute of the National Institutes of Health within the Department of Health and Human Services, under a $1.1 million time-and-materials delivery order awarded against the Medical Laboratory Testing and Analysis Services Federal Supply Schedule. Specifically, Quest Diagnostics will perform coagulopathy biomarker assays and send the results to NCI to support analyses...

This is a $2,502,392.00 definitive contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services (HHS), to Case Western Reserve University to establish a Tissue Source Site (TSS) Network in support of the Cancer Genome Atlas (TCGA) program. The contract has a period of performance through September 30, 2014 and does not have a set-aside designation. The purpose of the contract is to provide clinically annotated biospecimens to the TCGA's...

The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $5,900 purchase order to Akesogen, Inc.'s Tempus Labs, Inc. Division for DNA extraction from whole blood. The firm fixed price contract will be performed in Bethesda, Maryland over a one month period concluding in mid-February 2016. No set aside designation or subcontractors were indicated. The award supports the funding agency's biomedical research...

Genomic Testing Cooperative, LCA has been awarded a firm fixed price purchase order valued at fifteen thousand dollars by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract calls for the contractor to provide sequencing of bone marrow samples in order to aid patients' diagnosis and treatment guidance for diseases, as described in solicitation 24-007899. No set aside designation was applied to this award. Performance...

The National Heart, Lung and Blood Institute awarded a $24,000 purchase order contract to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California, for hematology panel sequencing and somatic mutation analysis services. The contract, which commenced on December 22, 2025 and extends through December 21, 2026, requires the contractor to conduct next-generation sequencing of bone marrow samples to identify somatic mutations that will provide guidance for...

The National Cancer Institute (NCI) awarded a delivery order contract valued at $11.67 million to the Research Institute at Nationwide Children's Hospital for the Center for Cancer Genomics (CCG) Biospecimen Core Resource. The contract, awarded on August 25, 2022, with an ultimate completion date of July 31, 2027, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at the contractor's facility in Columbus, Ohio. The Research Institute...